ARS Pharmaceuticals clinical trials we track

Check company identity source

Phase 2 3 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Determine the effect of ARS-2 (0.5 mg or 1 mg) versus placebo on itch and hive. After: Measure: Determine the effect of ARS-2 (0.5 mg or 1 mg) versus placebo on itch.

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Effect of ARS-1 versus Albuterol and placebo. After: Measure: Effect of ARS-1 Versus Albuterol and Placebo.

Check registry source

· 2 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Effect of ARS-1 versus placebo based on a patient reported pruritus/hive score. After: Measure: Effect of ARS-1 Versus Placebo Based on a Patient Reported Pruritus/Hive Score.

Actual enrollment decreased by 3 participants

Before: 24 participants (actual). After: 21 participants (actual).

Check registry source